SDoH are economic and social conditions that could impact an individual’s health. This can be assessed by third-party demographic information – such as zip code, socioeconomic factors, environmental concerns or other data – that affect the health of broader populations. This is important knowledge for providers to have since medical care is estimated to account for only 10% to 20% of the modifiable contributors to a health outcomes for a population. But PROs also are important in evaluating SDoH, since payors and providers are unlikely to infer transportation issues, food insecurity or other social conditions based solely on census data; they prefer to hear it directly from the patient.
The desire to improve population health and the lives of those with chronic conditions - while containing medical costs and eliminating unnecessary treatments - is fueling the momentum behind VBC. And it will get stronger, as providers embrace remote monitoring and patient-focused data, and payors extend more support for new technologies and processes to help providers succeed in delivering VBC.
About the Author: Joshua Claman is the CEO of Rimidi, a cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across populations. He has over 25 years leading technology businesses in Asia, Europe and the Americas. His industry experiences span his time in Dell in several senior executive positions, including the founding and development of Dell’s European Healthcare business, to his role as president of ReachLocal, one of the largest advertising technology companies in the U.S., and serving as the chief business officer of Stratasys, a leader in 3D printing in the medical field. Josh is a strong advocate for the promise of technology.
Back to HCB News
